Abstract:
본 발명은 오리 간염바이러스 1형(duck hepatitis virus type 1) 유전자의 감별진단방법(differential diagnostic method)에 관한 것으로, 더욱 상세하게는 2C 유전자, 캡시드(capsid) 유전자 및 5'-UTR(untranslated region) 유전자를 표적(target)하는 특이 프라이머를 사용하여 RT-PCR 방법으로 오리 간염바이러스 1형과 유전자형이 다른 오리 간염바이러스 유전자를 감별 진단하는 방법에 관한 것이다. 또한 본 발명에 따른 감별진단방법은 조류 유래의 다른 병원성 RNA 바이러스들과도 신속하고 정확하게 감별적으로 진단하는데 유용하다. 오리 간염바이러스 1형 및 아형, PCR, 5′-UTR 유전자, 캡시트 유전자, 3D 유전자
Abstract:
본 발명은 모기를 매개로 소에서 유사산을 일으키는 소 아까바네병, 츄잔병 및 아이노 바이러스 감염증 예방을 위한 아까바네(K-9), 츄잔(YoungAM) 및 아이노(KSA9910) 바이러스 균주를 이용한 3종 혼합 바이러스 백신 및 그 제조방법에 관한 것으로서, 보다 상세하게는 국내 분리주인 아까바네(K-9), 츄잔(YoungAM) 및 아이노(KSA9910) 바이러스 균주를 불활화시킨 후 이들을 면역증강제와 함께 혼합하여 제조함으로써 3가지 바이러스를 한가지 예방약으로 예방이 가능하도록 제조한 3종 혼합 바이러스 백신 및 그 제조방법에 관한 것이다. 소 아까바네병, 아이노바이러스 감염증, 츄잔병, 3종 혼합불활화 백신
Abstract:
A kit and a method for diagnosing a porcine epidemic diarrhea virus antigen are provided to diagnose the antigen conveniently and rapidly without a special testing equipment in a farm or a laboratory field. A kit for diagnosing a porcine epidemic diarrhea virus antigen is characterized in that a conjugate of a monoclonal antibody 6G15(deposition no. KCTC 10996BP) coupled to nucleocapside 58kDa of an epidemic diarrhea virus and a gold particle is attached to a reaction position of the porcine epidemic diarrhea virus antigen on a strip and a monoclonal antibody 9D11(deposition no. KCTC 10997BP) is attached to a position different from the coupling portion of the porcine epidemic diarrhea virus antigen and the monoclonal antibody 6G15. A method for diagnosing the porcine epidemic diarrhea virus antigen comprises the steps of: (a) loading a sample onto a detection pad on a strip; (b) reacting the conjugate of the monoclonal antibody 6G15 coupled to nucleocapside 58kDa of the epidemic diarrhea virus and the gold particle with the porcine epidemic diarrhea virus antigen in the sample; and (c) reacting the porcine epidemic diarrhea virus antigen, the monoclonal antibody 9D11 and the reaction product obtained from the step(b).
Abstract:
A viral vaccine containing isolated virus strains is provided to improve use safety and immunogenicity by using inactivated viruses, and increase production yield of cows, so that the vaccine is useful for prevention of abortion or stillbirth in cows caused by viruses via mediation of Culicoides spp. A viral vaccine for prevention of abortion or stillbirth in cows contains cultured medium of inactivated virus strains of akabane virus(K-9)(KCTC 18117P), chuzan virus(KSA9910)(KCTC 18118P) and aino virus(YoungAM)(KCTC 18119P), and is produced by: inactivating akabane virus(K-9)(KCTC 18117P), chuzan virus(KSA9910)(KCTC 18118P) and aino virus(YoungAM)(KCTC 18119P) by adding 0.1M BEI(binary ethylene imine) prepared by solubilizing 2-BEA(2-bromoethylamine) in 0.2N NaOH, and treating the solution in a constant temperature water bath of 37 deg. C for 1 hour to them; mixing the 3 kinds of viruses in a weight ratio of 1:1:1; and adding 40-60 wt.% of IMS 1314 as an immunomodulator into the viral mixture.
Abstract:
Recombinant proteins of enzootic bovine leukemia virus are provided to improve specificity and sensitivity of detection as compared with conventional antigens by expressing the envelope glycoproteins in baculovirus and secreting the envelope glycoproteins to insect cells. A method for producing a recombinant protein of enzootic bovine leukemia virus expressed in an insect cell comprises the steps of: (1) cloning an envelop glycoprotein of enzootic bovine leukemia virus from the blood of enzootic bovine leukemia positive cows to baculovirus and sequencing the cloned protein; (2) transforming an insect cell with a recombinant virus gene of SEQ ID NO:1 to express a recombinant protein of SEQ ID NO:2; and (3) purifying and concentrating the recombinant protein produced from the insect cell, wherein the recombinant virus gene of SEQ ID NO:1 is prepared by recombination of envelop glycoprotein genes including a whole gp51 gene and a part of gp30 gene.
Abstract translation:通过在杆状病毒中表达包膜糖蛋白并将包膜糖蛋白分泌到昆虫细胞中,提供了特异性和灵敏度的检测与常规抗原的特异性和灵敏度。 用于生产在昆虫细胞中表达的特异性牛白血病病毒重组蛋白质的方法包括以下步骤:(1)将来自地方性牛白血病阳性牛的血液中的特异性牛白血病病毒的包膜糖蛋白克隆至杆状病毒,并测序克隆的蛋白质 ; (2)用SEQ ID NO:1的重组病毒基因转化昆虫细胞以表达SEQ ID NO:2的重组蛋白; (3)从昆虫细胞产生的重组蛋白质的纯化和浓缩,其中通过包括整个gp51基因和一部分gp30基因的包膜糖蛋白基因的重组制备SEQ ID NO:1的重组病毒基因。
Abstract:
A diagnostic strip for a H5 type highly pathogenic avian influenza and general avian influenza is provided to conveniently and rapidly diagnose whether a bird is infected by the H5 type highly pathogenic avian influenza and general avian influenza or not from stool in situ without special testing equipment. The diagnostic strip is characterized in that a monoclonal antibody common to general avian influenza virus in which hemaglutinin antigens are H1 to H15 and a monoclonal antibody specific to a highly pathogenic avian influenza in which a hemaglutinin antigen is H5 are used for diagnosing the highly pathogenic and the general avian influenza in which the hemaglutinin antigen is H5 from stool or tissue of chicken. The method for preparing the diagnostic strip comprises the steps of: (a) respectively absorbing the monoclonal antibody specific to the highly pathogenic avian influenza virus in which the hemaglutinin antigen is H5 and the monoclonal antibody common to general avian influenza virus into a membrane; (b) respectively attaching the antibody absorbed membrane obtained from the step(a) to gold particles so as to prepare an antibody-gold conjugate and then mixing it; and (c) precipitating the conjugate obtained from the step(b) in a basic material and then drying it.
Abstract:
A virus strain for preparing a vaccine is provided to have excellent defending effect on low pathogenic avian influenza H9N2 virus strain. And a vaccine is provided to be able to effectively prevent diseases caused by the low pathogenic avian influenza H9N2 recording the high mortality of bird. The low pathogenic avian influenza H9N2 virus strain for preparing vaccine is characterized in that a motif of hemangioblast protein cleavage site amino acid sequence has TSGR and it shows the defending capacity against domestic low pathogenic avian influenza virus. The method for preparing a vaccine for the low pathogenic avian influenza H9N2 virus strain comprises the steps of: (a) inactivating the low pathogenic avian influenza H9N2 virus strain; and (b) mixing the inactivated virus with an adequate excipient.
Abstract:
본 발명은 바실러스 에스피 87 (KACC 91098) 및 이의 용도에 관한 것으로서, 상기 균주는 내산성, 내담즙성 및 생체 안전성이 인정되고, 병원성 세균 억제활성을 가지며, 장내에서 독립된 균총(Niche)으로서 미생물의 길항 작용을 통한 병원성 균총의 증식을 감소시켜 질병을 예방하는 효과가 있다.
Abstract:
본 발명은 항원-항체 반응을 이용하여 신속하게 돼지콜레라바이러스에 대한 항체의 존재유무를 검출할 수 있도록 고안된 검출 키트 및 이를 이용한 돼지콜레라바이러스 항체의 검출 방법에 관한 것이다. 돼지콜레라, 면역크로마토그라피, 골드 콘쥬게이트, 유전자 재조합
Abstract:
PURPOSE: Provided is a spike gene and a method for detecting neutralizing antibodies of porcine epidemic diarrhea virus to prevent porcine epidemic diarrhea by using spike proteins which are mass-produced through genetic engineering. CONSTITUTION: The spike gene obtained from porcine epidemic diarrhea virus is located in the gene of recombinant baculovirus (KFCC 11014). And a method for detecting neutralizing antibodies of porcine epidemic diarrhea virus (PEDV) is characterized by the next step of: using a spike protein expressed in recombinant baculovirus (KFCC 11014) as an antigen in implementing indirect-ELISA. A method for manufacturing the recombinant baculovirus (KFCC 11014) is comprised of the following steps of: i) making expression vector pVL 1393 having a spike gene of PEDV and obtaining a medium lacking serum but including linear baculovirus, and mixture containing lipopectin; and ii) cotransfecting host cell Sf9 using the mixture.